ANK2 and type 2 diabetes mellitus: The high levels of ankyrin-B expression in the brain and pancreatic beta cells and early senescence in ankyrin-B+/− mice suggests that human populations with age-related neurological disorders and/or type 2 diabetes should be evaluated for ANK2 variants.